Evidence map›Paper›PMID 27580596›Full record

ArticleScientific reports2016

A Multi-Serotype Approach Clarifies the Catabolite Control Protein A Regulon in the Major Human Pathogen Group A Streptococcus.

Sruti DebRoy, Miguel Saldaña, Dante Travisany, Andrew Montano, Jessica Galloway-Peña, Nicola Horstmann, Hui Yao, Mauricio González, Alejandro Maass, Mauricio Latorre and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Systematic analysis of the glucose-PTS inApplied and environmental microbiology · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. CcpA RegulatesAntibiotics (Basel, Switzerland) · 2022
    Article
  7. Article
  8. Article
  9. Integration of Biological Networks forFrontiers in molecular biosciences · 2019
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Sruti DebRoyDepartment of Infectious Diseases, MD Anderson Cancer Center, Houston, Texas, USA.
Miguel SaldañaDepartment of Infectious Diseases, MD Anderson Cancer Center, Houston, Texas, USA.
Dante TravisanyMathomics, Center for Mathematical Modeling, Universidad de Chile, Beauchef 851, 7th Floor, Santiago, Chile.
Andrew MontanoDepartment of Infectious Diseases, MD Anderson Cancer Center, Houston, Texas, USA.
Jessica Galloway-PeñaDepartment of Infectious Diseases, MD Anderson Cancer Center, Houston, Texas, USA.
Nicola HorstmannDepartment of Infectious Diseases, MD Anderson Cancer Center, Houston, Texas, USA.
Hui YaoDepartment of Bioinformatics and Computational Biology, MD Anderson Cancer Center, Houston, Texas, USA.
Mauricio GonzálezCenter for Genome Regulation (Fondap 15090007), Universidad de Chile, Blanco Encalada 2085, Santiago, Chile.
Alejandro MaassMathomics, Center for Mathematical Modeling, Universidad de Chile, Beauchef 851, 7th Floor, Santiago, Chile.
Mauricio LatorreMathomics, Center for Mathematical Modeling, Universidad de Chile, Beauchef 851, 7th Floor, Santiago, Chile.
Samuel A ShelburneDepartment of Infectious Diseases, MD Anderson Cancer Center, Houston, Texas, USA.
The University of Texas MD Anderson Cancer Center · USUniversity of Chile · CL

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Contribution of catabolite control protein A to group A streptococcal virulenceR01AI089891 · NIAID · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SHELBURNE, SAMUEL A · 2011 to 2015
$1.6M
NCI NIH HHS P30 CA016672NIAID NIH HHS R01 AI089891
6 · The paper itself

Abstract

Catabolite control protein A (CcpA) is a highly conserved, master regulator of carbon source utilization in gram-positive bacteria, but the CcpA regulon remains ill-defined. In this study we aimed to clarify the CcpA regulon by determining the impact of CcpA-inactivation on the virulence and transcriptome of three distinct serotypes of the major human pathogen Group A Streptococcus (GAS). CcpA-inactivation significantly decreased GAS virulence in a broad array of animal challenge models consistent with the idea that CcpA is critical to gram-positive bacterial pathogenesis. Via comparative transcriptomics, we established that the GAS CcpA core regulon is enriched for highly conserved CcpA binding motifs (i.e. cre sites). Conversely, strain-specific differences in the CcpA transcriptome seems to consist primarily of affected secondary networks. Refinement of cre site composition via analysis of the core regulon facilitated development of a modified cre consensus that shows promise for improved prediction of CcpA targets in other medically relevant gram-positive pathogens.

Indexed as

Gene Expression Regulation, BacterialRegulonTranscriptomeAnimalsBacterial ProteinsFemaleGene Expression ProfilingHumansMiceNucleotide MotifsRepressor ProteinsSerogroupStreptococcal InfectionsStreptococcus pyogenesSurvival AnalysisVirulenceBacterial Proteinscatabolite control proteins, bacteriaRepressor Proteins

Identifiers

PMID27580596
PMCPMC5007534
OpenAlexW2510846324

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.